SYDNEY: Asian shares advanced on Monday as investors breathed a sigh of relief after encouraging Chinese data suggested the world's second-biggest economy may be starting to stabilize thanks to ramped-up stimulus from Beijing. Second quarter economic growth slowed to 6.2per cent in the second ...
BEIJING: China's economic growth slowed to 6.2 per cent in the second quarter from a year earlier, the weakest pace in at least 27 years, as demand at home and abroad faltered amid an escalating trade war with the United States. Monday's official growth data marked a further loss of...
BEIJING: China's economic growth slowed to 6.2 per cent in the second quarter from a year earlier, the weakest pace in at least 27 years, as demand at home and abroad faltered amid an escalating trade war with the United States. Monday's official growth data marked a further loss of...
BOGOTA: Colombia has put a patch of banana crops in the north of the country under quarantine on suspicion they are infested with a fungus that is seen as potentially devastating to the country's banana exports, the agriculture minister said on Sunday (Jul 14). The fusarium R4T fungus causes...
This one case might well be remembered as the last case; ending the WTO and the rules-based multilateral trading system, say SMU’s Henry Gao and UNSW’s Weihuan Zhou.
Is it time to redefine professionalism? Founder and managing director of NeXT Career Consulting Group Paul Heng explores if and why employers still think looks matter.
Workers at seven Amazon sites across Germany will go on strike over pay for at least two days this week starting on Sunday night going into Monday, labor union Verdi said.
ECONOMIC pundits are concerned that Christine Lagarde's appointment as the new European Central Bank (ECB) chief will accelerate competitive devaluations of the euro, yen and other currencies against the US dollar.
E-WALLET operators in Singapore are eyeing a future as a digital bank as opportunities in the business-to-business space come to the fore.
Gilead Sciences Inc will invest US$5.1 billion to increase its stake in Galapagos NV and partner with the Belgian-Dutch biotech firm to develop and commercialize its treatments for a ten-year period, the companies said on Sunday.
